Jones Financial Companies
SLNO

Jones Financial Companies’s Soleno Therapeutics SLNO Stock Holding History

Jones Financial Companies’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-82
Closed -$2.46K – 5151
2026
Q1 		$2.46K Buy
82
+54
+193% +$2.12K ﹤0.01% 4092
2025
Q4 		$1.3K Hold
28
– – ﹤0.01% 3956
2025
Q3 		$1.82K Buy
28
+8
+40% +$593 ﹤0.01% 3728
2025
Q2 		$1.67K Hold
20
– – ﹤0.01% 3527
2025
Q1 		$1.44K Buy
+20
New +$974 ﹤0.01% 3321

Jones Financial Companies's SLNO Position: Q2 2026 in Review

Jones Financial Companies sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 82 shares — an estimated $2.46K sold.

Jones Financial Companies first reported a position in SLNO in Q1 2025 and held it in 5 quarters. The position peaked at $2.46K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

  • Jones Financial Companies reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jones Financial Companies sold 82 Soleno Therapeutics shares in Q2 2026, an estimated $2.46K.
  • Jones Financial Companies first reported a position in Soleno Therapeutics in Q1 2025 and held it in 5 quarters.
  • Jones Financial Companies's Soleno Therapeutics position peaked at $2.46K in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.